北美鼻腔输送设备市场预测至 2027 年 - COVID-19 影响和按药物类型(麻醉药、抗生素、止痛药、钙补充剂、血管收缩药、抗组胺药等)进行的区域分析;输送技术(喷雾剂、雾化器、吸入器等);最终用户(家庭护理机构、医院和诊所);和国家

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 122    |    Report Code: TIPRE00018194    |    Category: Life Sciences

North America Nasal Delivery Devices Market

市场介绍

药物输送系统是主要用于控制或靶向输送各种治疗剂以治疗各种疾病或改善病情的技术。患者的健康。鼻腔给药是有效的给药途径之一。它提供无针药物输送、脑靶向治疗的最佳途径以及卓越的生物利用度。鼻给药途径在多种疾病适应症中是优选的,例如帕金森病、前列腺癌、偏头痛和流感等。此外,经鼻给药也适用于治疗毒瘾以及镇静。

 

市场概况与动态< /strong>

北美

鼻腔输送装置市场预计将从 2019 年的 219.3247 亿美元增至 2027 年的 369.4074 亿美元。该市场预计将以2020 年至 2027 年复合年增长率为 6.8%。市场的增长归因于一些关键驱动因素,例如呼吸系统疾病患病率的上升以及患者鼻内给药的优异效果。然而,由于药物输送药物的限制,市场增长可能会受到阻碍。

 

关键细分市场

 

主要来源和上市公司

报告中包含的鼻腔输送设备市场的一些主要主要和二手来源是 全球哮喘网络、美国国家医学图书馆、国立卫生研究院< /p>

 

< u>购买报告的理由

  • 了解北方美国鼻腔输送设备市场格局并确定最有可能保证强劲回报的细分市场
  • 了解鼻腔输送设备市场不断变化的竞争格局,保持领先地位< /li>
  • 通过确定最有可能销售的细分市场,有效规划北美鼻腔输送设备市场的并购和合作交易
  • 帮助通过对鼻腔输送设备市场各个细分市场的市场表现进行敏锐和全面的分析,做出明智的业务决策
  • 获取北美地区 2019 年至 2027 年各个细分市场的市场收入预测< /li>

 

北美鼻腔输送设备市场细分

 < /p>

按药物类型

  • 麻醉药
  • 抗生素
  • 止痛药
  • 钙补充剂
  • 血管收缩药
  • 抗组胺药
  • 其他

 

按输送技术分类

  • 喷雾剂
  • 雾化器
  • 吸入器
  • 其他

 

作者最终用户

  • 家庭护理机构
  • 医院
  • 诊所

 

按国家/地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥

 

公司简介< /strong>

  • 葛兰素史克公司
  • 阿斯利康
  • 辉瑞公司< /li>
  • BD
  • 赛诺菲
  • 默克和有限公司
  • 卡迪拉制药有限公司
  • 诺华公司
  • Dr.雷迪实验室
  • Neurelis, Inc.
 

North America Nasal Delivery Devices Strategic Insights

Strategic insights for North America Nasal Delivery Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-nasal-delivery-devices-market-strategic-framework.webp
Get more information on this report

North America Nasal Delivery Devices Report Scope

Report Attribute Details
Market size in 2019 US$ 21,932.47 Million
Market Size by 2027 US$ 36,940.74 Million
Global CAGR (2020 - 2027) 6.8%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 药物类型
  • 麻醉药
  • 抗生素
  • 止痛药
  • 钙补充剂
  • 血管收缩剂
  • 抗组胺药
By 输送技术
  • 喷雾器
  • 雾化器
  • 吸入器
By 最终用户
  • 家庭护理机构
  • 医院
  • 诊所
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Reddys Laboratories
  • Neurelis, Inc.
  • Get more information on this report

    North America Nasal Delivery Devices Regional Insights

    The regional scope of North America Nasal Delivery Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-nasal-delivery-devices-market-geography.webp
    Get more information on this report

    The List of Companies - North America Nasal Delivery Devices Market

    1. GlaxoSmithKline plc.
    2. AstraZeneca
    3. Pfizer Inc.
    4. BD
    5. Sanofi
    6. Merck & Co., Inc.
    7. Cadila Pharmaceuticals Ltd.
    8. Novartis AG
    9. Dr. Reddy's Laboratories
    10. Neurelis, Inc.
    Frequently Asked Questions
    How big is the North America Nasal Delivery Devices Market?

    The North America Nasal Delivery Devices Market is valued at US$ 21,932.47 Million in 2019, it is projected to reach US$ 36,940.74 Million by 2027.

    What is the CAGR for North America Nasal Delivery Devices Market by (2020 - 2027)?

    As per our report North America Nasal Delivery Devices Market, the market size is valued at US$ 21,932.47 Million in 2019, projecting it to reach US$ 36,940.74 Million by 2027. This translates to a CAGR of approximately 6.8% during the forecast period.

    What segments are covered in this report?

    The North America Nasal Delivery Devices Market report typically cover these key segments-

  • 药物类型 (麻醉药, 抗生素, 止痛药, 钙补充剂, 血管收缩剂, 抗组胺药)
  • 输送技术 (喷雾器, 雾化器, 吸入器)
  • 最终用户 (家庭护理机构, 医院, 诊所)
  • What is the historic period, base year, and forecast period taken for North America Nasal Delivery Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Nasal Delivery Devices Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Nasal Delivery Devices Market?

    The North America Nasal Delivery Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • BD
  • Sanofi
  • Merck & Co., Inc.
  • Cadila Pharmaceuticals Ltd.
  • Novartis AG
  • Dr. Reddys Laboratories
  • Neurelis, Inc.
  • Who should buy this report?

    The North America Nasal Delivery Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Nasal Delivery Devices Market value chain can benefit from the information contained in a comprehensive market report.